CompletedNot Applicable

An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS

United States1,250 participantsStarted 2008-09

Plain-language summary

To determine the prevalence of MRSA isolates with marginal susceptibility to vancomycin or heteroresistance.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Isolates of MRSA from PAL samples Exclusion Criteria: * None

What they're measuring

Determine the prevalence of PAL hetero-VISA within MRSA isolates using vancomycin E-tests and contrast this with E-tests for teicoplanin, linezolid and tigecycline.

Timeframe: 1 time

Trial details

NCT IDNCT00754273

SponsorUniversity of Kentucky

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-07

View on ClinicalTrials.gov More Methicillin-resistant Staphylococcal Aureus Pneumonia trials